Teva Launches LongActingImpact.com for Schizophrenia Care
Parsippany, New Jersey, USA & Tel Aviv, Israel, September 16, 2026 Teva Pharmaceuticals has launched LongActingImpact.com, a new educational...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Parsippany, New Jersey, USA & Tel Aviv, Israel, September 16, 2026 Teva Pharmaceuticals has launched LongActingImpact.com, a new educational...
Austin, Texas, USA, September 16, 2026 Sling Therapeutics, Inc. has announced that the first patients have been dosed in...
Pittsburgh, Pennsylvania, USA, September 15, 2026 The Braff Group has announced that its client, Community Clinical Research (CCR) of...
Edmonton, Alberta, Canada, September 2, 2026 Aurora Cannabis Inc., a global medical cannabis company, has urged its shareholders to...
Bridgewater, N.J., August 10, 2026 Grifols announced the completion of patient follow-up in SPARTA, its Phase 3 outcomes study...
Bridgewater, N.J., August 10, 2026 Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC, creating a scaled,...
NASHVILLE, Tenn., August 6, 2026 Harrow Inc. announced it has entered into a definitive agreement to acquire the global...
Boston & Bedford, Massachusetts, August 3, 2026 Curium and Lantheus Holdings, Inc. have entered into a definitive merger agreement...
ALPHARETTA, GEORGIA & NEW YORK, USA, April 14, 2026 Avanos Medical, Inc. has entered into a definitive agreement to...
NEW YORK, April 8, 2026 Avista Healthcare Partners has announced the acquisition of Bentec Medical from Greyrock Capital Group...
